Funder: Breakthrough T1D
Due Dates: Rolling (LOI and applications accepted year-round; RFA-specific deadlines may apply)
Funding Amounts: Typically up to $3,000,000 total for up to 3 years; requires company-matched funds; no indirect costs.
Summary: Supports for-profit entities conducting research and development of therapies or devices for type 1 diabetes closely aligned with Breakthrough T1D’s priorities.
Key Information: Requires company matching funds and initial discussion with Breakthrough T1D staff before LOI submission.